| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -75,968 | 33,004 | -65,712 | -108,494 |
| Share-based compensation expense | 11,639 | 8,069 | 7,495 | 13,427 |
| Depreciation expense | 576 | 412 | 356 | 565 |
| Accretion of asset retirement obligation | 10 | 322 | 23 | NaN |
| Non-cash lease expense | 639 | 618 | 621 | 972 |
| Accretion of net investment discounts | 3,246 | 2,759 | 3,291 | 9,537 |
| Gains on sale of non-financial assets | NaN | 10,249 | NaN | NaN |
| Other receivable | -100,000 | 100,000 | NaN | NaN |
| Prepaid expenses and other current assets | 7,988 | 9,127 | 2,177 | 5,109 |
| Other non-current assets | 4,838 | -5,882 | 397 | 1,096 |
| Accounts payable | -4,967 | -5,007 | 8,806 | 966 |
| Accrued expenses and other current liabilities | -134 | 15,022 | 3,881 | 2,611 |
| Operating lease liabilities | -695 | -603 | -601 | -1,092 |
| Other non-current liabilities | 206 | NaN | NaN | NaN |
| Net cash provided by (used in) operating activities | 15,234 | -64,416 | -50,996 | -106,787 |
| Purchases of short-term investments | 647,468 | 93,623 | 248,824 | 204,932 |
| Proceeds from maturities of short-term investments | 151,703 | 146,168 | 195,919 | 288,453 |
| Purchases of property and equipment | 1,182 | 1,496 | 1,572 | 546 |
| Advance payment received for sale of non-financial asset | NaN | NaN | 5,158 | NaN |
| Proceeds from sale of non-financial asset | NaN | 10,249 | NaN | NaN |
| Net cash (used in) provided by investing activities | -496,947 | 56,140 | -49,319 | 82,975 |
| Proceeds from issuance of ordinary shares-At Market Common Stock Offering Program | NaN | 0 | 57,058 | NaN |
| Proceeds from issuance of ordinary shares-Follow On Offering | NaN | 608,650 | NaN | NaN |
| Proceeds from issuance of pre-funded warrants in 2025 follow-on offering, net of underwriting discounts and commissions | NaN | 94,000 | NaN | NaN |
| Payments of offering costs | 37 | 1,250 | 770 | NaN |
| Proceeds from issuance of ordinary shares under employee share purchase plan | NaN | 447 | 0 | 474 |
| Proceeds from exercise of share options | 869 | 3,140 | 377 | 1,008 |
| Payment of taxes on restricted share units withheld for taxes | 2,574 | 0 | 462 | 156 |
| Net cash (used in) provided by financing activities | -1,742 | 704,987 | 56,203 | 1,326 |
| Net change in cash and cash equivalents | -483,455 | 696,711 | -44,112 | -22,486 |
| Beginning of the period | 799,623 | 66,598 | 169,510 | NaN |
| End of the period | 316,168 | 696,711 | 102,912 | NaN |
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR)